Fig. 5

In vivo anti-tumor efficacy of BSO&OXA@MOF-LR. a Photographs of tumors obtained on day 12 after various treatments. b Quantitative analysis of tumor mass 12 days after different treatments (n = 3). c Tumor growth curve of different groups (n = 3). d Survival curve of mice after they received different treatments (n = 3). e Representative hematoxylin and eosin staining images of tumor slices at the end of the efficacy experiment (scale bar: 100 μm). * p < 0.05, ** p < 0.01. OXA oxaliplatin; DFO deferoxamine